Skip to main content
Signal8

Levisetti Matteo

SEC insider (Form 3/4/5 filer). CIK 0001962444. Chief Medical Officer at Cue Biopharma, Inc. (CUE). 1 reported Form 4/5 transaction since Sep 2024; latest on Mar 21, 2025. Located in BOSTON, MA.

Companies Levisetti Matteo has filed insider reports for

  • Cue Biopharma, Inc. (CUE): Officer, Chief Medical Officer
Levisetti Matteo profile photo

Levisetti Matteo

CIK: 0001962444

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Cue Biopharma, Inc. logo
CUE

Cue Biopharma, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Cue Biopharma, Inc. logo
    CUE

    Cue Biopharma, Inc.

    Mar 21, 2025
    Award

    Stock Option (right to buy)

    Direct
    250K shares-

1-1 of 1